Autoantibodies in connective tissuedisease

Research output: Contribution to journalReview article

Abstract

Autoimmune connective tissue diseases are heterogeneous rheumatic diseases with the potential to affect multiple body systems. Autoantibodies are a characteristic feature of these diseases and are typically highly disease specific. In addition to aiding diagnosis, many autoantibodies have established associations with clinically important disease complications including internal organ involvement. In this chapter, we review the autoantibodies relevant to autoimmune connective tissue diseases, excluding systemic lupus erythematosus, with particular reference to the associated clinical features and how identification of such an autoantibody may inform prognosis and clinical management. We also discuss the practicalities of testing for autoantibodies along with potential difficulties and pitfalls.

Original languageEnglish
Article number101462
JournalBest Practice and Research Clinical Rheumatology
Early online date14 Dec 2019
DOIs
Publication statusE-pub ahead of print - 14 Dec 2019

Keywords

  • Anti-nuclear autoantibody
  • Autoantibodies
  • Connective tissue disease

ASJC Scopus subject areas

  • Rheumatology

Cite this

Autoantibodies in connective tissuedisease. / Mulhearn, Ben; Tansley, Sarah L; McHugh, Neil J.

In: Best Practice and Research Clinical Rheumatology , 14.12.2019.

Research output: Contribution to journalReview article

@article{a1c4e038c11d417d87077118badec75b,
title = "Autoantibodies in connective tissuedisease",
abstract = "Autoimmune connective tissue diseases are heterogeneous rheumatic diseases with the potential to affect multiple body systems. Autoantibodies are a characteristic feature of these diseases and are typically highly disease specific. In addition to aiding diagnosis, many autoantibodies have established associations with clinically important disease complications including internal organ involvement. In this chapter, we review the autoantibodies relevant to autoimmune connective tissue diseases, excluding systemic lupus erythematosus, with particular reference to the associated clinical features and how identification of such an autoantibody may inform prognosis and clinical management. We also discuss the practicalities of testing for autoantibodies along with potential difficulties and pitfalls.",
keywords = "Anti-nuclear autoantibody, Autoantibodies, Connective tissue disease",
author = "Ben Mulhearn and Tansley, {Sarah L} and McHugh, {Neil J}",
note = "Copyright {\circledC} 2019 Elsevier Ltd. All rights reserved.",
year = "2019",
month = "12",
day = "14",
doi = "10.1016/j.berh.2019.101462",
language = "English",
journal = "Best Practice and Research Clinical Rheumatology",
issn = "1521-6942",
publisher = "Elsevier",

}

TY - JOUR

T1 - Autoantibodies in connective tissuedisease

AU - Mulhearn, Ben

AU - Tansley, Sarah L

AU - McHugh, Neil J

N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.

PY - 2019/12/14

Y1 - 2019/12/14

N2 - Autoimmune connective tissue diseases are heterogeneous rheumatic diseases with the potential to affect multiple body systems. Autoantibodies are a characteristic feature of these diseases and are typically highly disease specific. In addition to aiding diagnosis, many autoantibodies have established associations with clinically important disease complications including internal organ involvement. In this chapter, we review the autoantibodies relevant to autoimmune connective tissue diseases, excluding systemic lupus erythematosus, with particular reference to the associated clinical features and how identification of such an autoantibody may inform prognosis and clinical management. We also discuss the practicalities of testing for autoantibodies along with potential difficulties and pitfalls.

AB - Autoimmune connective tissue diseases are heterogeneous rheumatic diseases with the potential to affect multiple body systems. Autoantibodies are a characteristic feature of these diseases and are typically highly disease specific. In addition to aiding diagnosis, many autoantibodies have established associations with clinically important disease complications including internal organ involvement. In this chapter, we review the autoantibodies relevant to autoimmune connective tissue diseases, excluding systemic lupus erythematosus, with particular reference to the associated clinical features and how identification of such an autoantibody may inform prognosis and clinical management. We also discuss the practicalities of testing for autoantibodies along with potential difficulties and pitfalls.

KW - Anti-nuclear autoantibody

KW - Autoantibodies

KW - Connective tissue disease

UR - http://www.scopus.com/inward/record.url?scp=85076515616&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2019.101462

DO - 10.1016/j.berh.2019.101462

M3 - Review article

C2 - 31848055

JO - Best Practice and Research Clinical Rheumatology

JF - Best Practice and Research Clinical Rheumatology

SN - 1521-6942

M1 - 101462

ER -